Unleashing the Immune System in Advanced NSCLC - CME-Certified

Society for Immunotherapy of Cancer (SITC) and Medscape Oncology are excited to announce our seventh activity, "Unleashing the Immune System in Advanced NSCLC." The goal of this activity is to provide an update on emerging immunotherapies in advanced NSCLC, as well as patient selection criteria for enrollment in clinical trials investigating these agents.

This activity is part of Clinical Advances in Immuno-Oncology, a new, robust online learning center designed to provide oncologists with FREE, CME-certified education on the topic of immunotherapy. This online learning center was developed through a strategic partnership between SITC and Medscape, and it includes a variety of CME-certified educational activities.

During this engaging program, participants will be prompted to answer questions related to the activity, and physicians can earn a maximum of 0.50 AMA PRA Category 1 Credits™. Throughout 2014, SITC and Medscape will release additional unique CME-certified activities covering topics ranging from immunology fundamentals to tumor-specific immunotherapy education. Please stay tuned for additional activities to come!

Previously Released Activities

	Emerging Paradigms in the Treatment of Advanced Melanoma ^CME Drs Weber, Margolin, and Robert discuss issues related to current and emerging immunotherapies for advanced melanoma. August 25, 2014
	New Opportunities: Immunotherapies in Advanced NSCLC ^CME Interested in an update on use of immunotherapy in patients with advanced NSCLC? Get one here. August 15, 2014
	Manipulating the Immune System in Melanoma to Restore Immune-Mediated Tumor Control ^CME Dr Jeffrey Weber reviews the emergence of immunotherapy to treat advanced melanoma. June 19, 201
	Immune Checkpoint Inhibition: Unfettered T Cells Can Control and Eliminate Tumors ^CME Dr. Govindan leads a discussion with Dr. Ferris and Dr. Spigel on the application of immune strategies and therapies for cancer. May 28, 2014
	Tumor Immunity: Exploring the Role of a Checkpoint ^CME Review this illustrated discussion from Dr. Nora Disis of the immune system and checkpoints in the development and treatment of tumors. May 13, 2014
	Concepts in Immuno-Oncology: Understanding the Key Players ^CME Learn about adaptive immunity and immune checkpoints. April 30, 2014

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org

Join us on:

You have received this message because you have had previous contact with the Society for Immunotherapy of Cancer. If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.

Please add info@sitcancer.org to your safe senders list.